Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Hill: The ADVANTAGE seeding trial: a review of internal documents. (0.12 sec) 

The ADVANTAGE seeding trial: a review of internal documents

- Free from Publisher
KP Hill, JS Ross, DS Egilman, HM Krumholz - Annals of Internal Medicine, 2008 - Am Coll Physicians
Background: Seeding trials, clinical studies conducted by pharmaceutical
companies that are designed to seem as if they answer a scientific question but
primarily fulfill marketing objectives, have not been described in detail.
Cited by 25 - Related articles - All 6 versions

Seeding Trials: Just Say “No”


HC Sox, D Rennie - Annals of Internal Medicine, 2008 - Am Coll Physicians
Why would a drug company go to the expense and bother of conducting a trial
involving hundreds of practitioners—each recruiting a few patients—when a
study based at a few large medical centers could accomplish the same ...
Cited by 12 - Related articles - All 3 versions

Clinical trial investigators and their prescribing patterns: another dimension to the …


BM Psaty, D Rennie - JAMA, 2006 - Am Med Assoc
In this issue of JAMA, Andersen and colleagues 5 report the findings of an
observational study that assessed the association between physician
participation in a clinical trial of an asthma drug and the prescribing ...
Cited by 12 - Related articles - BL Direct - All 4 versions

[CITATION] «House of Commons» britannique au parlement belge [Editorial]


MD De Meyere - MinervaF, 2005
Cited by 3 - Related articles

[CITATION] Une demi-vérité: le récit des coxibs [Editorial]


M van Driel - MinervaF, 2003
Cited by 5 - Related articles

Guest authorship and ghostwriting in publications related to rofecoxib: a case study of …

- rcpe.ac.uk [PDF] 
JS Ross, KP Hill, DS Egilman, HM Krumholz - JAMA, 2008 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Authorship in ...
Cited by 97 - Related articles - BL Direct - All 9 versions

Characteristics and impact of drug detailing for gabapentin


MA Steinman, GM Harper, M Chren, CS … - PLoS Medicine, 2007 - medicine.plosjournals.org
Market research forms that describe detail visits for gabapentin became
available through litigation that alleged that gabapentin was promoted for
“off-label” uses. Forms were available for 97 physicians reporting on ...
Cited by 14 - Related articles - Cached - BL Direct - All 9 versions

Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive …

- washington.edu [PDF] 
BM Psaty, RA Kronmal - Jama, 2008 - Am Med Assoc
Sponsors have a marketing interest to represent their products in the best
light. This approach conflicts with scientific standards that require the
symmetric and comparable reporting of safety and efficacy data. Selective ...
Cited by 54 - Related articles - BL Direct - All 7 versions

[CITATION] ADVANTAGE Study Group, et al. Gastrointestinal tolerability and effectiveness of rofecoxib …


JR Lisse, M Perlman, G Johansson, JR … - Reactions
Cited by 15 - Related articles

[CITATION] Merck mörkade uppgifter om överdödlighet i Vioxx-studier


F Hedlund - Läkartidningen 2008-04-16. http://www. lakartidningen. se …
Cited by 2 - Related articles


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google